It's worth taking a second look at the healthcare giant.

Historical patterns indicate that abrupt fluctuations in the market can impact any firm, regardless of its seeming dominance.

For Q3 FY26, Pfizer reported a net profit of Rs 141.8 crore, up 11.1 per cent year-on-year (YoY), compared with Rs 127.6 ...

Is Pfizer stock a buy at under 9x earnings? Yes. It is.

Pfizer Inc. remains a Strong Buy, offering compelling value with a 6.32% dividend yield and a P/E Non-GAAP of 8.43. Learn ...

Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets with lower revenues. "Current financial guidance does not anticipate any ...

The stock has been fairly stable over the past year.

The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.

Pfizer posted adjusted earnings of 66 cents per share, beating the 57 cents forecast by analysts, News.Az reports, citing foreign ...

Analysts expect Pfizer’s revenue to decrease approximately 5% to around $16.95 billion, while adjusted earnings per share are projected to fall 9.5% to 57 cents compared to 63 cents in the same period ...

The stock gained 10.35% to hit intraday highs of ₹5,257, continuing its gaining streak from Monday, when it closed 3.79% ...

What does a successful retirement look like? If it means financial security through steady income sources, then you can get ...